• Ophthalmic Business Council

    For more than 25 years, the Foundation has facilitated the Ophthalmic Business Council (OBC) with the goal of fostering communication among leaders in the ophthalmic community. The OBC provides an ideal forum for thought leaders from the Academy, industry, government and health policy to collaborate face-to-face on ways to improve patient care.

    OBC members are invited to attend two essential symposia with unparalleled networking opportunities with Academy physician leaders and industry experts.

    To join or learn more, contact Todd Lyckberg at 415.447.0361 or tlyckberg@aao.org.

    Download brochures: AAO 2021-22 exhibitors and non-exhibitors

    Save the Date


    Spring 2021 Symposium
    April 9, 2021
    Virtual Meeting - 1:00 p.m. (EDT) / 10:00 a.m. (PDT)

    Held every other year, the Spring Symposium focuses on the latest first-hand from experts on FDA, Medicare and reimbursement issues. As the speed of innovation grows, this event helps you navigate the complexities of introducing new technologies and treatments to patients. Unlike the Fall Symposium, Academy leaders do not attend this meeting.

     

    Fall 2021 Symposium
    Sept. 9-10, 2021
    San Francisco, Calif.

    Held in conjunction with the Academy’s Board of Trustees meeting, the Fall Symposium covers the most timely and relevant issues facing ophthalmology today. In-depth presentations and open-forum discussions allow you to hear from all perspectives: physician, industry, health policy and government. The Fall Symposium is the perfect way to gain meaningful insights from key players.

     

    Member Benefits

    2020 - 2021 Ophthalmic Business Council 

     
    Platinum Benefactors ($35,000)
    Biogen
    Novartis Pharmaceuticals
     
    Crown Benefactors ($25,000)
    Alcon, Inc.
    Allergan, an AbbVie Company
    Genentech, Inc.
    Horizon Therapeutics
    Mallinckrodt Pharmaceuticals
    Optos, Inc.
    Regeneron Pharmaceuticals, Inc.

    Benefactors ($15,000)
    Bausch + Lomb
    Johnson & Johnson Vision
    Santen, Inc.
     
    Patrons ($7,500)
    Aerie Pharmaceuticals, Inc.
    Bio-Tissue, Inc.
    Boehringer Ingelheim
    Carl Zeiss Meditec, Inc.
    Dompé
    EyePoint Pharmaceuticals
    Glaukos Corporation
    Leadiant Biosciences, Inc.
    REGENXBIO, Inc.
    Spark Therapeutics, Inc.
    Verana Health

    Subscribers ($5,000)
    Apellis Pharmaceuticals
    Ivantis, Inc.
    Nevakar, Inc.
    Sight Sciences, Inc.

    Members ($2,500)
    Immunovant, Inc.
    MicroOptx
    Notal Vision
    Omeros Corporation
    Sun Ophthalmics
    Vareant Health
    W. L. Gore & Associates